Search Results

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR therapy RYE BROOK, N.Y., December , – The U.S. Food and Drug Administr…

FDA Approves Combination Treatment for Lymphoma Subtype that has Returned or Worsened

WASHINGTON, February , – The U.S. Food and Drug Administration has approved brentuximab vedotin (Adcetris®) to treat adults with large lymphoma, who…

FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type

The Leukemia & Lymphoma Society has provided funding to research that identified novel ways to attack the IDH mutation in patients with blood cancers.…

FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype

RYE BROOK, N.Y., March , – The U.S. Food and Drug Administration approved zanubrutinib (Brukinsa®) in combination with obinutuzumab (Gazyva®) to trea…

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors RYE BROOK, N.Y., December , – The…

Communities Across the U.S. to Join Olympians at Legendary Deer Valley Resort to End Blood Cancer

Communities Across the U.S. to Join Olympians at Legendary Deer Valley Resort to End Blood Cancer

New Report Reveals “Hidden” Patient Costs of Healthcare Consolidation

WASHINGTON, D.C. – The price of cancer care—and the amount patients are forced to pay for it—is rising at an alarming rate. A new report reveals the s…

Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types

The FDA approval will benefit children and adults with acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). RYE BROOK, N.Y., January , …

Judy

Meet Judy, a leukemia survivor, and teacher. Given a death sentence of chronic myeloid leukemia (CML), Oregon native Judy prepared to have her ashes s…

New LLS Docuseries on CAR T-cell Advances Aims to Educate and Empower Blood Cancer Patients

Patient Accounts Provide Unique InsightWASHINGTON, MARCH , – The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood canc…

New Formulation of Important CML Drug Comes with No Mealtime Restrictions

Nilotinib is a targeted treatment that offers control of CML RYE BROOK, N.Y., December , – The U.S. Food and Drug Administration (FDA) has approved …

New $20 Million Research Funding Program Aims to ‘Accelerate a Cure’ for Follicular Lymphoma

The Leukemia & Lymphoma Society and the Institute for Follicular Lymphoma Innovation commit $ million to jointly fund follicular lymphoma research.RYE…

Nearly 1 in 2 Patients with Medical Debt Feel “Trapped”, New Poll from Leading Healthcare Orgs Finds

Almost of patients would blame elected officials if they fail to act.

MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER

Funds Raised to Benefit the Work of LLS’s The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Su…

Communities Nationwide Are Stepping Up to Help Patients Live Longer Better Lives

WASHINGTON, February , – The Leukemia & Lymphoma Society’s (LLS)’s fundraising event, Big Climb officially kicks off nationwide on February and will…

Region Finder

Cycling Enthusiasts to Embark on One-of-a-Kind Adventure to Support Blood Cancer Patients Nationwide

The Leukemia & Lymphoma Society’s Picturesque Scenic Shore Bike Tour on Lake Michigan Shoreline offers a Unique Ride Experience to Help Drive its Life…

Cyclists Take On America’s Most Beautiful Bike Ride In Support Of Blood Cancer Patients

The Leukemia & Lymphoma Society’s (LLS) Annual Cycling Event in Lake Tahoe, a Winner in USA Today’s 10Best Readers’ Choice Award for Best Road Cyclin…

FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia

Blinatumomab will now be available for adults and kids with newly diagnosed RYE BROOK, N.Y., June , – The U.S. Food and Drug Administration on Frida…

FDA Approves New Drug for the Most Common Form of Leukemia in Adults

The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™). Pirtobrutinib is the only , reversable Bruton’s tyrosine kinase (BTK) i…

LLS Applauds FDA’s Expanded Approval of Medication to Treat Blood Disorder in Adults with Myelodysplastic Syndromes

This approval marks a step in the right direction toward bettering a patient’s quality of life, says LLS’s Chief Scientific Officer Lee Greenberger, P…

The Leukemia & Lymphoma Society Teams Up with Kappa Alpha Psi Fraternity To Educate And Empower Communities About Blood Cancer

Collaboration Efforts Designed to Advance Health Education and Address Racial Disparities in Blood Cancers Affecting Black Communities

The Leukemia & Lymphoma Society's Response to the Israel-Hamas War

The following message was sent to all LLS employees on October , : Dear LLS Community,   As an organization, The Leukemia & Lymphoma Society (LLS) is …

The Leukemia & Lymphoma Society Receives Grant Award from Disabled Veterans National Foundation

Rye Brook, NY- July , – The Leukemia & Lymphoma Society (LLS) is honored to announce it has received a grant from the Disabled Veterans National Foun…

The Leukemia & Lymphoma Society Receives $17 Million from the Mike and Sofia Segal Family Foundation to Accelerate Progress in the Treatment of Chronic Myelomonocytic Leukemia

Mike and Sofia Segal, who immigrated to the U.S. from Ukraine in , lead foundation that supports overlooked and underfunded causes, including rare di…